Prepulse Inhibition (PPI)
Overview
Prepulse inhibition (PPI) is an operational measure of sensorimotor gating in which a weak, non-startling acoustic stimulus (the prepulse) presented 30-500 ms before a startling pulse reduces the magnitude of the startle reflex. The prepulse is typically 3-12 dB above background noise and too brief to evoke a startle response on its own, yet it activates brainstem and mesopontine cholinergic circuits that dampen the subsequent startle. This automatic filtering mechanism is mediated by a circuit involving the inferior colliculus, pedunculopontine tegmental nucleus, and caudal pontine reticular nucleus, and is modulated top-down by cortical and limbic inputs through the nucleus accumbens and ventral pallidum.
PPI deficits are a translational biomarker for schizophrenia, as patients exhibit reduced sensorimotor gating that correlates with sensory flooding and cognitive fragmentation. The primary dependent variable is percent PPI, calculated as 100 multiplied by one minus the ratio of startle amplitude on prepulse trials to startle amplitude on pulse-alone trials. Multiple prepulse intensities (e.g., 4, 8, and 12 dB above background) are tested in pseudorandom order to generate an intensity-response curve, with higher prepulse intensities normally producing greater inhibition. Habituation controls (pulse-alone blocks at the start and end of the session) verify that changes in startle amplitude are not confounded by simple habituation or sensitization.
ConductMaze integrates with a piezoelectric or accelerometer-based startle platform to capture whole-body startle amplitude with sub-millisecond timing resolution. The software automatically delivers programmable acoustic stimuli through calibrated speakers, randomizes trial types with configurable intertrial intervals, and computes percent PPI at each prepulse intensity along with mean startle amplitude and habituation indices. Session data are exported with trial-by-trial waveform peaks, enabling post-hoc analysis of startle onset latency, peak latency, and waveform morphology for detailed pharmacological profiling.
Trial Flow
System Calibration
Calibrate speaker output (dB SPL) and accelerometer sensitivity on the startle platform
Acclimation Period
Place animal in restrainer on platform; present background noise (65-70 dB) for 5-min acclimation
Habituation Block
Deliver 5-6 pulse-alone trials to stabilize baseline startle amplitude
PPI Test Block
Present randomized pulse-alone, prepulse+pulse, and no-stimulus trials across 60-80 trials
Prepulse Detection
Classify each trial by prepulse intensity (none, +4, +8, +12 dB) and record startle peak
End Habituation Block
Deliver 5-6 additional pulse-alone trials to assess within-session habituation
PPI Calculation
Compute %PPI at each prepulse level: 100 × (1 − prepulse_trial / pulse_alone)
Session End
Remove animal from restrainer; export trial-by-trial waveform data and summary statistics
Parameters
| Parameter | Type | Default | Description |
|---|---|---|---|
| Background Noise | integer | 68 | Continuous white-noise background level in dB SPL |
| Pulse Intensity | integer | 120 | Startling pulse intensity in dB SPL (typically 110-120) |
| Pulse Duration | integer | 40 | Duration of the startle pulse in milliseconds |
| Prepulse Intensities | enum | 4,8,12 | Prepulse levels above background in dB (comma-separated) |
| Prepulse Duration | integer | 20 | Duration of the prepulse stimulus in milliseconds |
| Interstimulus Interval | integer | 100 | Interval between prepulse offset and pulse onset in milliseconds |
| Intertrial Interval | duration | 15 | Mean interval between trials in seconds (randomized ±5 s) |
| Acclimation Duration | duration | 300 | Acclimation period in the restrainer before testing begins in seconds |
| Total Test Trials | integer | 72 | Number of trials in the main PPI test block |
| Startle Window | integer | 100 | Time window after pulse onset to capture peak startle amplitude in milliseconds |
Metrics
| Metric | Unit | Description |
|---|---|---|
| PPI at +4 dB | % | Percent prepulse inhibition at 4 dB above background |
| PPI at +8 dB | % | Percent prepulse inhibition at 8 dB above background |
| PPI at +12 dB | % | Percent prepulse inhibition at 12 dB above background |
| Mean Startle Amplitude | mV | Average peak startle response on pulse-alone trials |
| Startle Habituation | % | Percent reduction in startle from first to last pulse-alone block |
| Startle Onset Latency | ms | Time from pulse onset to first detectable response deflection |
| Peak Startle Latency | ms | Time from pulse onset to maximum response amplitude |
Sample Data
| Subject | Treatment | Startle Amplitude (mV) | PPI +4 dB (%) | PPI +8 dB (%) | PPI +12 dB (%) | Habituation (%) |
|---|
Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.
Applications
- 1Schizophrenia modeling — quantifying sensorimotor gating deficits induced by NMDA antagonists, dopamine agonists, or isolation rearing
- 2Antipsychotic screening — evaluating typical and atypical antipsychotics for restoration of PPI in pharmacological or genetic models
- 3Neurodevelopmental disorders — assessing PPI deficits in autism, fragile X, and 22q11.2 deletion syndrome mouse models
- 4Translational biomarker — direct cross-species comparison with human PPI paradigms for drug development
Related Protocols
Compatible Products
Ready to Automate Your Behavioral Protocols?
Contact us for a demo and pricing information.
